AU2599699A - Droperidol compositions and method for using same - Google Patents

Droperidol compositions and method for using same

Info

Publication number
AU2599699A
AU2599699A AU25996/99A AU2599699A AU2599699A AU 2599699 A AU2599699 A AU 2599699A AU 25996/99 A AU25996/99 A AU 25996/99A AU 2599699 A AU2599699 A AU 2599699A AU 2599699 A AU2599699 A AU 2599699A
Authority
AU
Australia
Prior art keywords
droperidol
compositions
same
droperidol compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25996/99A
Inventor
Abu Alam
Pablo J. Cruz
Keith Glad
Dennis Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akorn Operating Co LLC
Original Assignee
Taylor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/022,436 external-priority patent/US5997884A/en
Priority claimed from US09/133,106 external-priority patent/US5990134A/en
Priority claimed from US09/177,996 external-priority patent/US5981552A/en
Application filed by Taylor Pharmaceuticals Inc filed Critical Taylor Pharmaceuticals Inc
Publication of AU2599699A publication Critical patent/AU2599699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
AU25996/99A 1998-02-12 1999-02-11 Droperidol compositions and method for using same Abandoned AU2599699A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09022436 1998-02-12
US09/022,436 US5997884A (en) 1998-02-12 1998-02-12 Compositions and method for treating migraine
US09133106 1998-08-12
US09/133,106 US5990134A (en) 1998-08-12 1998-08-12 Oral droperidol compositions and method for treating migraine
US17799798A 1998-10-23 1998-10-23
US09177996 1998-10-23
US09177997 1998-10-23
US09/177,996 US5981552A (en) 1998-10-23 1998-10-23 Sublingual and buccal compositions of droperidol and method for treating migraine
PCT/US1999/003059 WO1999040900A1 (en) 1998-02-12 1999-02-11 Droperidol compositions and method for using same

Publications (1)

Publication Number Publication Date
AU2599699A true AU2599699A (en) 1999-08-30

Family

ID=27487110

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25996/99A Abandoned AU2599699A (en) 1998-02-12 1999-02-11 Droperidol compositions and method for using same

Country Status (2)

Country Link
AU (1) AU2599699A (en)
WO (1) WO1999040900A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030337A2 (en) * 1999-10-22 2001-05-03 Orbon Corporation Ophthalmic formulation of dopamine antagonists
US20110288061A1 (en) * 2010-05-18 2011-11-24 National Cheng Kung University Triterpenoid derivatives, benzenoid derivatives and pharmaceutical compositions containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03232817A (en) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk Application agent
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
WO1999040900A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
AU6111699A (en) Novel method and compounds
AU7960200A (en) Sealing composition and sealing method
AU3767097A (en) Shampoo compositions and method
GB2348808B (en) Methods and compositions for desensitisation
AU5338099A (en) Method of advertising
HUP9900960A3 (en) Disinfecting compositions and method for disinfecting surfaces
AUPO976797A0 (en) Method and composition (III)
AU2349399A (en) R-lansoprazole compositions and methods
AU8019598A (en) Composition and method for providing glutamine
AUPO976597A0 (en) Method and composition (I)
AU7685798A (en) Compositions and methods for preventing adhesion
GB9624501D0 (en) Insecticial compositions and method
AU1391699A (en) Composition and method for insulating foam
GB9803506D0 (en) Composition and method
AU7050098A (en) Drilling method and system using foam - foaming composition
AU3936699A (en) Novel vinca-alkaloid derivatives and preparation method
AUPN137895A0 (en) Composition and method
AU2599699A (en) Droperidol compositions and method for using same
AUPO982097A0 (en) Methods and compositions for use therein
AU3900499A (en) (+)-hydroxyrisperidone compositions and methods
AU6149699A (en) Pesticide composition and method
AU3901399A (en) Dust control composition and method
AU1061200A (en) Decontamination method and composition therefor
AU7287798A (en) Compositions and methods for bioremediation
GB9811908D0 (en) Method and composition for dietry supplements

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase